Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pinana JL et al. – The findings suggest that CMV is still a major concern in alloHSCT–RIC. Variables associated with poor anti–CMV T–cell recovery (that is, GVHD and donor type) are helpful in identifying patients at higher risk for CMV–D in the alloHSCT–RIC setting.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address